Intratumoral Ral-binding protein 1 (RalBP1) expression as a potential predictor of bevacizumab treatment efficacy in patients with ovarian cancer. This is an ASCO Meeting Abstract from the 2024 ASCO ...

Reuse of this image is restricted and requires permission from the publisher.

A phase II multicentric trial of S-1 combined with24 h-infusion of cisplatin in patients with advanced gastric cancer ...